Alodia

Manufacturing, exporting, and supplying ethical pharmaceutical products with a focus on cardiac and diabetic treatments.

About Alodia

Alodia is a Healthcare company. Manufacturing, exporting, and supplying ethical pharmaceutical products with a focus on cardiac and diabetic treatments. Its Indian entity Alodia Life Sciences Private Limited reported revenue of β‚Ή3.17 Cr. Alodia offers products and services including Alosar and Alovas. Its focus areas include Pharmaceuticals, Drug Manufacturing, Cardiac and Diabetic Treatments and Research and Development.

Company details

Alodia is identified as a young and fast-growing ethical pharmaceutical organization that manufactures and exports products for cardiac and diabetic diseases. Research and development efforts are directed towards translating advanced science into effective therapies, emphasizing human responsibilities and ethical practices. The companys mission involves thriving with passion and compassion, while products like Alosar and Alovas are provided to support health needs. Operations are conducted with a commitment to innovation and well-being, ensuring remedies are developed day and night for global supply.

Key Metrics
  • Indian entity revenue
    ₹3.17 Cr

    FY 2025 · -69% YoY

  • Indian entity net profit
    ₹34.7 Lakh

    FY 2025 · 11% margin

  • Indian entity EBITDA
    ₹75.9 Lakh

    FY 2025 · 24% margin

Products & Services of Alodia

Alodia offers a comprehensive portfolio of products and services, including Alosar and Alovas.

Alosar
Cardiac Drugs

This product is developed as a combination of Losartan Potassium and Amlodipine for managing hypertension and related conditions

Alovas
Cholesterol Management

This product is formulated as Atorvastatin tablets for addressing cholesterol levels and supporting cardiovascular health

Board of directors of Alodia Life Sciences Private Limited (Alodia)

Alodia Life Sciences Private Limited is the primary company behind Alodia. The board of Alodia Life Sciences Private Limited currently have 2 directors; the longest-serving is Amit Gupta, appointed in 2009. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Amit Gupta
DIN 02473166
Managing Director02 Dec 200916 yrs 11 moAlodia Life Sciences Private Limited
Yugam Gupta
DIN 08704736
Director26 Feb 20206 yrs 8 moAlodia Life Sciences Private Limited

Financials of Alodia

Figures of Alodia Life Sciences Private Limited, the primary company behind Alodia, for FY 2025. Revenue was ₹3.17 Cr (-69% year on year). Net profit was ₹34.7 Lakh (11% margin). EBITDA was ₹75.9 Lakh (24% margin). Revenue has grown at a compounded annual rate of -56% over three years and -33% over five years.

  • ₹3.17 CrRevenue · FY 2025 · -69% YoY
  • ₹34.7 LakhNet profit · 11% margin
  • ₹75.9 LakhEBITDA · 24% margin
  • ₹1.2 LakhPaid-up capital
  • -56%Revenue CAGR, 3 years
  • -33%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Alodia Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for Alodia

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Alodia

The primary company behind Alodia, Alodia Life Sciences Private Limited, reported revenue of β‚Ή3.17 Cr for FY 2025, down 69% year on year.

Alodia is identified as a young and fast-growing ethical pharmaceutical organization that manufactures and exports products for cardiac and diabetic diseases. Research and development efforts are directed towards translating advanced science into effective therapies, emphasizing human responsibilities and ethical practices. The companys mission involves thriving with passion and compassion, while products like Alosar and Alovas are provided to support health needs. Operations are conducted with a commitment to innovation and well-being, ensuring remedies are developed day and night for global supply.

Alodia offers Alosar and Alovas.

Alodia operates through Alodia Life Sciences Private Limited.

The legal entities of Alodia currently have 2 directors, including Yugam Gupta, Amit Gupta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available